Lactistat Liquid
NDC Package 44911-0336-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Lactistat (arsenicum album, calcarea carbonica, cocculus indicus, graphites, hydrofluoricum acidum, lachesis mutus, lacticum acidum, rhus tox, ruta graveolens, sarcolacticum acidum, saccharum officinale) liquids is muscle weakness, assists in decreasing lactic acid buildup.****These statements are based upon traditional homeopathic practice. This formulation utilizes a liquid delivery system. Marketed by Energique, Inc., this product is identified by NDC 44911-0336.

Identification & Billing

NDC Package Code
44911-0336-1
Package Description
30 mL in 1 BOTTLE, DROPPER
Product Code
11-Digit Billing Format
44911033601

Clinical Specifications

Proprietary Name
Lactistat
Non-Proprietary Name
Arsenicum Album, Calcarea Carbonica, Cocculus Indicus, Graphites, Hydrofluoricum Acidum, Lachesis Mutus, Lacticum Acidum, Rhus Tox, Ruta Graveolens, Sarcolacticum Acidum, Saccharum Officinale
Substance Name
Anamirta Cocculus Seed; Arsenic Trioxide; Graphite; Hydrofluoric Acid; Lachesis Muta Venom; Lactic Acid, Dl-; Lactic Acid, L-; Oyster Shell Calcium Carbonate, Crude; Ruta Graveolens Flowering Top; Sucrose; Toxicodendron Pubescens Leaf
Dosage Form
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route
Oral - Administration to or by way of the mouth.
Usage Information
Muscle weakness, assists in decreasing lactic acid buildup.****These statements are based upon traditional homeopathic practice. They have not been reviewed by the Food and Drug Administration. Muscle weakness, assists in decreasing lactic acid buildup.****These statements are based upon traditional homeopathic practice. They have not been reviewed by the Food and Drug Administration.

Regulatory & Marketing

Labeler Name
Energique, Inc.
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
03-30-2016
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 44911-0336-1 identifies a specific commercial package of 30 ml in 1 bottle, dropper of Lactistat, a human over the counter drug labeled by Energique, Inc.. This liquid is formulated for oral use and contains anamirta cocculus seed; arsenic trioxide; graphite; hydrofluoric acid; lachesis muta venom; lactic acid, dl-; lactic acid, l-; oyster shell calcium carbonate, crude; ruta graveolens flowering top; sucrose; toxicodendron pubescens leaf as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Energique, Inc. on March 30, 2016. The current certification is valid through December 31, 2026.

How is this Energique, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 44911033601. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
44911-0336-1
11-Digit CMS (5-4-2)
44911-0336-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.